BioProcess International

Viral Vector Manufacturing Simplified: A Sponsor’s Guide to Smarter CDMO Partnerships

Accelerate CGT developement with strategic viral vector manufacturing and CDMO partnerships that balance quality, cost, and ...

LumaCyte Analytical Method Included in Newly Published ISO Global Standard for Viral Vector Quantification

LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...
Des Moines Register

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing and quality control services. SHIRLEY, NY, UNITED ...
The Manila Times

Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to the OXB AAV and LV viral vector platforms

Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), today announces that it has entered into a ...

Cell and Gene Therapy Manufacturing Market to Reach USD 146.2 Billion by 2032 Amid Rising Demand for Personalized Therapies, Viral Vector Capacity, and Automated Bioprocessing ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
The Desert Sun

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

* Viral Vector Analysis Services Creative Biolabs provides a full range of viral vector analytical solutions with advanced equipment and technology, including AAV vector analysis, lentiviral vector ...

OXB enters into licensing agreement with Viral Vector Manufacturing Facility (VVMF), providing access to its AAV and LV viral vector platforms

Next step in a broader collaboration to support VVMF build viral vector manufacturing capabilities Oxford, UK – 18 March 2026: OXB (LSE: OXB), a ...
The Bakersfield Californian

Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to ...

Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), today announces that it has ...